| abstract |
The present invention relates to anti-tumor necrosis factor (TNF)-alpha antibodies, antigen-binding fragments thereof, and their uses for the prevention and treatment of pathological disorders mediated by TNF-alpha, e.g., autoimmune diseases or inflammatory disorders or conditions, e.g., an inflammatory arthritis (e.g., rheumatoid arthritis, psoriatic arthritis, axial spondyloarthritis). |